Laurent Kremer Selected Research

copper tetra(4-N-methylpyridyl)porphine

1/2018

B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent Kremer Research Topics

Disease

49	Tuberculosis (Tuberculoses) 09/2022 - 05/2002
32	Infections 01/2022 - 12/2002
8	Granuloma 01/2022 - 03/2007
6	Abscess 01/2020 - 03/2014
5	Multiple Sclerosis 09/2022 - 01/2020
5	COVID-19 02/2022 - 01/2021
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2019 - 11/2017
3	Bacterial Infections (Bacterial Infection) 12/2020 - 03/2002
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2020 - 01/2015
3	Cystic Fibrosis (Mucoviscidosis) 01/2017 - 01/2016
3	Latent Infection 05/2014 - 03/2007
2	Relapsing-Remitting Multiple Sclerosis 06/2022 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2020
2	Communicable Diseases (Infectious Diseases) 12/2020 - 03/2002
2	Lung Diseases (Lung Disease) 01/2019 - 11/2016
2	Latent Tuberculosis 01/2018 - 03/2007
2	Nontuberculous Mycobacterium Infections 01/2017 - 10/2016
1	Homocysteinemia 02/2022
1	Disease Progression 01/2022
1	Susac Syndrome 01/2022
1	Opportunistic Infections (Opportunistic Infection) 11/2021
1	Reinfection 01/2021
1	Progressive Multifocal Leukoencephalopathy 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Sarcoidosis (Schaumann Disease) 01/2020
1	Embryo Loss 01/2020

Drug/Important Bio-Agent (IBA)

16	Mycolic Acids (Mycolic Acid)IBA 09/2022 - 08/2005
14	Pharmaceutical PreparationsIBA 11/2019 - 05/2002
9	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 07/2008
6	Biological ProductsIBA 01/2022 - 07/2004
6	LipidsIBA 11/2021 - 01/2016
5	Isoniazid (Ftivazide)FDA LinkGeneric 09/2022 - 06/2003
5	EnzymesIBA 09/2022 - 01/2011
5	AntibodiesIBA 01/2021 - 01/2011
4	bedaquiline (R207910)IBA 01/2020 - 11/2017
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2004
4	lipoarabinomannan (LAM)IBA 11/2007 - 05/2002
3	Fingolimod Hydrochloride (FTY720)FDA Link 06/2022 - 03/2019
3	Triglycerides (Triacylglycerol)IBA 11/2021 - 11/2016
3	Immunoglobulin G (IgG)IBA 01/2021 - 12/2002
3	Imipenem FDA Link 01/2020 - 04/2015
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 12/2008
3	AcidsIBA 01/2017 - 03/2007
3	VaccinesIBA 10/2016 - 07/2004
3	serpentine (alkaloid)IBA 03/2016 - 03/2014
3	lipomannanIBA 11/2007 - 05/2002
2	Oxidoreductases (Dehydrogenase)IBA 09/2022 - 06/2003
2	Natalizumab (Tysabri)FDA Link 06/2022 - 01/2021
2	MonosaccharidesIBA 01/2022 - 09/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 01/2021
2	Clarithromycin (Biaxin)FDA LinkGeneric 10/2021 - 01/2017
2	CytokinesIBA 01/2020 - 03/2002
2	trehalose monomycolateIBA 11/2019 - 10/2019
2	AminoglycosidesIBA 11/2019 - 01/2017
2	arabinogalactanIBA 10/2019 - 01/2018
2	Clofazimine (Lamprene)FDA Link 10/2019 - 01/2019
2	TrehaloseIBA 10/2019 - 01/2018
2	CarbonIBA 01/2019 - 11/2016
2	AntigensIBA 01/2018 - 12/2002
2	LactamsIBA 01/2017 - 04/2015
2	Coloring Agents (Dyes)IBA 01/2017 - 03/2007
2	TAC AlternateIBA 01/2017 - 03/2007
2	Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric 01/2017 - 04/2015
2	Hydro-Lyases (Dehydratases)IBA 01/2016 - 06/2015
2	Protein Kinases (Protein Kinase)IBA 06/2013 - 04/2010
2	Serine (L-Serine)FDA Link 06/2013 - 01/2012
2	HydrolasesIBA 01/2012 - 01/2004
2	Phosphotransferases (Kinase)IBA 07/2009 - 03/2008
2	Inositol (Myoinositol)IBA 03/2007 - 05/2002
2	MannosidesIBA 03/2007 - 05/2002
2	Type II Fatty Acid SynthaseIBA 10/2006 - 08/2005
2	Orlistat (Xenical)FDA Link 08/2005 - 01/2004
1	ocrelizumabIBA 06/2022
1	Nitrous Oxide (Laughing Gas)IBA 02/2022
1	AutoantibodiesIBA 01/2022
1	BenzaldehydesIBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Infliximab (Remicade)FDA Link 01/2022
1	IsatinIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Nonesterified Fatty Acids (NEFA)IBA 11/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2021
1	nitazoxanide (NTZ)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Peptides (Polypeptides)IBA 12/2020
1	TetraspaninsIBA 12/2020
1	Peptidoglycan (Murein)IBA 10/2020
1	mycolylarabinogalactanIBA 10/2020
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Aligeron (AS 2)IBA 01/2020
1	Contactin 1IBA 01/2020
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020
1	MorpholinosIBA 01/2020

Therapy/Procedure

9	Therapeutics 09/2022 - 07/2008
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2017
2	Immunotherapy 09/2022 - 01/2022